MediPharm Labs (MEDIF) News Today $0.06 +0.00 (+0.73%) As of 01:56 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock MEDIF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Medipharm Labs reports Q2 revenue $11.8M vs. $10.4M last yearAugust 14, 2025 | msn.comMediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical CannabisAugust 14, 2025 | globenewswire.comMediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United StatesAugust 13, 2025 | prnewswire.comMediPharm Labs Sets Date to Report Second Quarter 2025 Financial ResultsAugust 11, 2025 | financialpost.comFMediPharm Labs Sets Date to Report Second Quarter 2025 Financial ResultsAugust 11, 2025 | globenewswire.comMediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime InhalerJuly 24, 2025 | globenewswire.comMediPharm Labs Corp.: MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of ShareholdersJune 17, 2025 | finanznachrichten.deMediPharm Announces Voting Results from the 2025 Annual and Special Meeting of ShareholdersJune 17, 2025 | globenewswire.comMediPharm Cautions Shareholders To Await Final Results of Annual and Special MeetingJune 16, 2025 | globenewswire.comApollo Capital Wins Proxy Contest at MediPharm LabsJune 16, 2025 | globenewswire.comMedipharm announces Glass Lewis recommends shareholders vote for all nomineesJune 14, 2025 | finance.yahoo.comLeading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director NomineesJune 13, 2025 | globenewswire.comMediPharm Reminds Shareholders to Vote in Advance of June 13 DeadlineJune 11, 2025 | financialpost.comFMediPharm Reminds Shareholders to Vote in Advance of June 13 DeadlineJune 11, 2025 | globenewswire.comApollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World’s Leading International Medical Cannabis CompanyJune 11, 2025 | uk.finance.yahoo.comMediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special MeetingJune 11, 2025 | globenewswire.comApollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World's Leading International Medical Cannabis CompanyJune 11, 2025 | globenewswire.comApollo Technology Capital Corporation: MediPharm Labs' Founder-CEO Pat McCutcheon Throws his Support behind Apollo Capital as DissidentJune 10, 2025 | finanznachrichten.deMediPharm Labs' Founder-CEO Pat McCutcheon Throws his Support behind Apollo Capital as DissidentJune 9, 2025 | globenewswire.comMediPharm Labs' Board Continues Value Destruction for Shareholders with Sale of Hope FacilityJune 6, 2025 | globenewswire.comMediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee FacilityJune 5, 2025 | globenewswire.comLeading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo's Arguments and Director SlateJune 2, 2025 | globenewswire.comMediPharm Labs Refuses to Answer Direct Questions Regarding Credible Securities Fraud Allegations Says Apollo CapitalMay 30, 2025 | globenewswire.comApollo Capital alleges securities fraud at Medipharm LabsMay 30, 2025 | finance.yahoo.comMediPharm Labs Responds to Fabricated Allegations from Dissident ShareholderMay 29, 2025 | financialpost.comFMediPharm Labs Responds to Fabricated Allegations from Dissident ShareholderMay 29, 2025 | globenewswire.comAlleged Securities Fraud at MediPharm Labs Says Apollo CapitalMay 29, 2025 | globenewswire.comMediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident PlanMay 28, 2025 | globenewswire.comWhat is going on with MediPharm Labs?May 26, 2025 | msn.comMediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution AgreementMay 26, 2025 | globenewswire.comMediPharm Labs Cautions Shareholders about Dissident Nominees' Governance Failures at Check-Cap Ltd.May 23, 2025 | globenewswire.comApollo Capital Comments on MediPharm Labs' Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual MeetingMay 23, 2025 | globenewswire.comApollo Capital seeks overhaul at MediPharm LabsMay 22, 2025 | investing.comMediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in JuneMay 22, 2025 | globenewswire.comApollo Capital Issues a With Prejudice Offer to MediPharm Labs and Its Board of Directors to Ensure Shareholder Rights Are Protected at the 2025 Annual MeetingMay 21, 2025 | globenewswire.comMediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation FilingsMay 21, 2025 | financialpost.comFMediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation FilingsMay 21, 2025 | globenewswire.comCOMPLETE Board Change is Urgently Needed at MediPharm Labs! Apollo Technology Capital Corporation Files Amended and Restated Proxy Circular Detailing Prolonged Underperformance, Strategic Failures, Excessive Executive Compensation, and Troubling Lack of Transparency Under Current LeadershipMay 20, 2025 | prnewswire.comApollo Capital Warns MediPharm Shareholders of Continued Value Destruction and Insolvency Risk Following Disastrous Q1 Financial ResultsMay 16, 2025 | prnewswire.comMediPharm Labs Corp (MEDIF) Q1 2025 Earnings Call Highlights: Record Gross Margin and ...May 15, 2025 | finance.yahoo.comMediPharm Labs Raises Concerns About Poorly Qualified Dissident NomineesMay 15, 2025 | prnewswire.comMediPharm Labs Corp. (MEDIF) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comApollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with ShareholdersMay 14, 2025 | prnewswire.comMediPharm Labs Announces Strong Q1 2025 ResultsMay 14, 2025 | prnewswire.comMediPharm Labs Sets Date to Report First Quarter 2025 Financial ResultsMay 9, 2025 | prnewswire.comMediPharm Labs Responds to Dissident Shareholder's FilingMay 8, 2025 | prnewswire.comApollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value DestructionMay 8, 2025 | prnewswire.comMediPharm Labs Corp.: MediPharm Labs Reports Full Year & Fourth Quarter 2024 ResultsMarch 31, 2025 | finanznachrichten.deMediPharm sees significant financial improvements in 2024March 31, 2025 | msn.comMediPharm Labs Reports Full Year & Fourth Quarter 2024 ResultsMarch 31, 2025 | prnewswire.com Get MediPharm Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDIF and its competitors with MarketBeat's FREE daily newsletter. Email Address MEDIF Media Mentions By Week MEDIF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MEDIF News Sentiment▼0.000.54▲Average Medical News Sentiment MEDIF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MEDIF Articles This Week▼01▲MEDIF Articles Average Week Get MediPharm Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDIF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TGIFF News FFNTF News ABSCF News LBTSF News AZFL News ERBB News AVTBF News AVCNF News BIOYF News CBGL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MEDIF) was last updated on 8/22/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access